Key Takeaways
  • "99% purity means 99% of the vial is peptide" — wrong. Purity and net peptide content are different measurements.
  • "You need to inject near the injury site" — for most peptides, subcutaneous injection anywhere provides systemic distribution.
  • "More is better" — peptide responses plateau. Doubling the dose rarely doubles the effect and increases side effects.
  • "Peptides are unregulated and dangerous" — research peptides from quality suppliers undergo rigorous analytical testing.
  • "BPC-157 is proven to heal injuries in humans" — the evidence is strong in animals, but human clinical trial data doesn't exist yet.

Myth 1: "99% Purity Means 99% of the Vial Is Peptide"

Reality: HPLC purity and net peptide content are different things. A vial labeled 5mg at 99% HPLC purity might contain only 3.5-4mg of actual peptide — the rest is TFA counterion salt and residual moisture from lyophilization. The 99% refers to the ratio of correct peptide to peptide impurities, not to overall vial composition. See our purity standards article for the full explanation.

Myth 2: "You Need to Inject Near the Injury Site"

Reality: For most research peptides (BPC-157, TB-500, GH secretagogues), subcutaneous injection anywhere provides systemic distribution through the bloodstream. The peptide reaches the injury site via circulation, not by physically traveling through tissue from the injection point. There's limited evidence that local injection near an injury might provide slightly higher local concentrations, but the standard abdominal or thigh injection sites are effective for systemic delivery.

Myth 3: "More Is Better"

Reality: Peptide receptor systems exhibit saturation kinetics. Above a certain dose, additional peptide doesn't produce proportionally more effect because the available receptors are already occupied. What you do get: more side effects. Dose-response curves plateau, but side-effect curves keep climbing. The research community's standard doses exist for a reason — they represent the sweet spot of the dose-response curve.

Myth 4: "All Peptide Suppliers Are Basically the Same"

Reality: Quality varies enormously. Independent testing of products from different suppliers has shown purity ranging from 60% to 99%+ for the same peptide. Some samples have contained the wrong peptide entirely, or no peptide at all. Supplier selection is the most important quality control decision you make. See our supplier evaluation guide.

Myth 5: "Peptides Are Just Like Steroids"

Reality: Peptides and anabolic steroids are completely different classes of molecules with different mechanisms. Steroids are small lipophilic molecules that bind intracellular receptors and directly alter gene transcription. Peptides are short amino acid chains that bind cell-surface receptors and trigger signaling cascades. The side effect profiles, risks, regulatory status, and biological effects are fundamentally different.

Myth 6: "The Research Proves This Works in Humans"

Reality: For most research peptides (BPC-157, TB-500, Epithalon, MOTS-C), the evidence base is primarily animal studies. Animal results don't automatically translate to humans. The history of drug development is full of compounds that showed dramatic results in mice and failed in human trials. Be honest about the evidence level: promising animal data is not the same as proven human efficacy.

Myth 7: "Peptide Side Effects Are Rare and Mild"

Reality: GLP-1 agonists cause nausea in 20-25% of users. GH secretagogues cause water retention and can affect blood sugar. Injection site reactions are universal. Most side effects are manageable, but dismissing them as "rare" sets unrealistic expectations. See our side effects guide for honest information.

Myth 8: "Reconstituted Peptides Last for Months in the Fridge"

Reality: The standard shelf life for reconstituted peptides in BAC water at 2-8°C is 4-6 weeks. Some peptides may be stable longer; many start degrading sooner. Claiming months of stability for a reconstituted vial is not supported by stability data. Store properly and use within the recommended window.

Myth 9: "I Don't Need to Keep a Log"

Reality: Without a research log, you're relying on memory and confirmation bias. A log turns your experience into data. It's the difference between "I think it's helping" and "my sleep quality scores have improved from 5.2 average to 7.1 average over 3 weeks." The latter is actionable information.

Myth 10: "Peptides Can Replace Medical Care"

Reality: Research peptides are tools for investigation, not substitutes for proven medical treatments. If you have a medical condition, see a doctor. Peptide research can complement medical care with your physician's knowledge and consent, but it should never replace it. Self-treating serious conditions with research-grade peptides while avoiding medical evaluation is not responsible research — it's dangerous.

Further Reading
Industry
Choosing a Supplier

Not all suppliers are equal — here's how to tell.

 Industry
Purity Standards

What purity numbers actually mean.

 Industry
Research Ethics

Responsible practices for the community.

 Supplies
Research Peptide Supplier

Browse third-party tested, American-made research peptides with certificates of analysis.

 Reference
Certificates of Analysis

View independent lab testing results including HPLC purity and mass spectrometry data.

References

  1. Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015;20(1):122-128. PubMed
  2. Henninot A, Collins JC, Nuss JM. The current state of peptide drug discovery: Back to the future? J Med Chem. 2018;61(4):1382-1414. PubMed
  3. Muttenthaler M, et al. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309-325. PubMed
  4. Lau JL, Dunn MK. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorg Med Chem. 2018;26(10):2700-2707. PubMed